Biokine – New Overall Survival Data From Phase 2a Study for BL-8040 in r/r AML Patients – CBI
Homepage /  Press Release /  Biokine – New Overall Survival Data From Phase 2a Study for BL-8040 in r/r AML Patients

Press Release

Biokine – New Overall Survival Data From Phase 2a Study for BL-8040 in r/r AML Patients